Targeting the gut to improve seizure control in CDKL5 deficiency disorder (CDD): study protocol for a single-arm, open-label clinical trial
Authors
- Emerenziana Ottaviano (ORCID: https://orcid.org/0000-0003-3839-2698)
- Elisa Borghi (ORCID: https://orcid.org/0000-0002-1893-0455)
- Aglaia Vignoli (ORCID: https://orcid.org/0000-0003-4638-4663)
- Paola Tognini (ORCID: https://orcid.org/0000-0001-7055-4701)
- Emilia Ricci (ORCID: https://orcid.org/0000-0002-3405-6454)
- Francesca Triva (ORCID: https://orcid.org/0009-0005-5785-6795)
- Matteo Domenico Marsiglia (ORCID: https://orcid.org/0009-0009-3421-9223)
- Marco Montecucco
Institutions
- Scuola Superiore Sant'Anna (IT)
- University of Milan (IT)
- Rina Services (Italy) (IT)
- Azienda Socio Sanitaria Territoriale Lariana (IT)